Ellen Bortniker

Ellen Bortniker is an accomplished professional in the field of pharmacovigilance, currently serving as Associate Director of Pharmacovigilance Americas at Haleon since June 2022. Prior to this role, Ellen Bortniker held several leadership positions at LEO Pharma from December 2013 to June 2022, including Director of Medical Information and Communication and Director of Pharmacovigilance. Ellen Bortniker's expertise encompasses handling drug safety reports, ensuring compliance with regulatory requirements, implementing corrective actions, and training internal and external staff on pharmacovigilance practices. Ellen Bortniker has also worked in various capacities at Bayer HealthCare, Schering-Plough Pharmaceuticals, Barr Pharmaceuticals, and Markus Research, establishing a robust foundation in drug safety and risk management throughout a career that spans over two decades. Ellen Bortniker holds a degree in Pharmacy from LIU Brooklyn and a BS in Psychology from Stony Brook University.